Powder: -20°C for 3 years | In solvent: -80°C for 1 year
McN5691 is a voltage sensitive calcium channel blocker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | McN5691 is a voltage sensitive calcium channel blocker. |
In vitro | McN5691 causes complete high affinity inhibition (Kd=39.5 nM) of specific diltiazem binding to the benzothiazepine receptor on the voltage-sensitive calcium channel in skeletal muscle microsomal membranes. In contrast to diltiazem, McN5691 inhibits specific dihydropyridine receptor binding, but the effect is biphasic with high (Kd=4.7 nM) and low (Kd=919.8 nM) affinity components. McN5691 inhibits norepinephrine (NE)-induced contraction (10 μM) and calcium uptake (1 and 10 μM) and causes concentration-dependent relaxation (EC50=159 μM) of 1 μM NE-contracted rings of rabbit thoracic aorta[1].McN5691 (1 and 10 μM) prevents 60 mM KCl-induced contraction and calcium uptake and causes concentration-dependent relaxation (EC50=190 μM) of 30 mM KCl-contracted aortic rings.?At or below 10 μM, McN5691 (McN-5691) has no effects on basal tone or calcium uptake (45Ca) in isolated rings of rabbit thoracic aorta. |
In vivo | McN5691, a chemical compound studied for its antihypertensive properties, undergoes extensive metabolism in dogs, with negligible amounts remaining unchanged in urine (less than 0.1%) and feces (19%) within the first 24 and 48 hours, respectively, and 36% detectable in plasma after 4 hours. A comparative study on McN5691 (McN-5691) revealed that its vascular resistance effects are notably higher in spontaneously hypertensive rats (SHR) compared to Wistar-Kyoto rats (WKY), with significant differences observed in the cerebellum and midbrain. Further investigation into McN5691's (RWJ-26240) excretion and metabolism in beagle dogs highlighted that a predominant portion of a radioactive dose (96.8%) is excreted through feces, with only a minor fraction (2.8%) eliminated via urine within seven days following the oral administration of 14C-McN5691, corroborating that over 87% of the dose is expelled through feces within the first 48 hours. |
Synonyms | RWJ26240 |
Molecular Weight | 457.6 |
Formula | C30H35NO3 |
CAS No. | 99254-95-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
McN5691 99254-95-2 Membrane transporter/Ion channel Metabolism Calcium Channel RWJ-26240 RWJ 26240 McN 5691 RWJ26240 McN-5691 inhibitor inhibit